Lexicon Pharmaceuticals Inc (LXRX) — Cash Flow Reinvestment Rate
Lexicon Pharmaceuticals Inc (LXRX) has a Cash Flow Reinvestment Rate of 0.91x as of June 2025, reinvesting $15.48 Million (capex $0.00 plus investments $15.48 Million) from operating cash flow of $16.99 Million. Check LXRX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Lexicon Pharmaceuticals Inc Cash Flow Reinvestment Rate (2005–2019)
Historical reinvestment intensity for Lexicon Pharmaceuticals Inc across 3 annual periods. Explore LXRX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Lexicon Pharmaceuticals Inc (2005–2019)
Year-by-year capital reinvestment analysis for Lexicon Pharmaceuticals Inc. For live market cap and broader valuation context, see Lexicon Pharmaceuticals Inc (LXRX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.37x | $155.85 Million | $113.81 Million | $70.00K | ▲ +115.6% |
| 2015 | 0.64x | $117.36 Million | $184.78 Million | $910.00K | ▲ +32.0% |
| 2005 | 0.48x | $11.28 Million | $23.44 Million | $11.28 Million | — |